Article Details
Retrieved on: 2025-03-05 14:59:09
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the growth of the cancer monoclonal antibodies market, driven by rising cancer rates and innovations in biopharmaceuticals. This relates to the biotech key concept through monoclonal antibodies and involves tags like specialty drugs and companies like Genmab and Seagen.
Article found on: www.openpr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here